AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KJUN 164 min read$PBH

Prestige Consumer Healthcare Inc. (PBH): Completion of Acquisition or Disposition of Assets

Prestige Consumer Healthcare Inc. (PBH) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001295947 0001295947 2026-06-12 2026-06-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of repor

Original reporting
SEC EDGAR 8-K
Published Jun 16, 2026, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 10:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefMergers & acquisitions
Primary signal
$PBH
Neutral
medium confidence
Mentioned
$PBH
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PBHNeutralMed
01

Why it matters

The disclosed debt terms (interest benchmark, quarterly amortization, mandatory prepayments, and leverage-based excess cash flow trigger) affect PBH’s future cash flows and refinancing risk ahead of the expected LaCorium close in Q2 FY2027.

02

Market read

Debt financing specifics for PBH’s acquisition plan provide actionable leverage/credit-risk context for traders.

03

What to watch

Covenant headroom and the ABL Amendment terms (not fully shown in the excerpt) could be the real driver of credit risk and equity sensitivity.

Relevance 7/10Novelty 8/10Timing: Filed June 16, 2026; closing date June 12, 2026

Background

Prestige Consumer Healthcare filed an SEC 8-K describing entry into a Term Loan Credit Agreement and an ABL Credit Agreement amendment tied to acquisition financing.

Company-level read

Ticker impact

$PBHNeutralMedium confidence
Context

PBH entered a $1.045B term-loan facility to finance transactions and permits a second draw for the LaCorium acquisition.

Expected impact

Likely modest near-term credit/spread sensitivity; equity reaction depends on perceived leverage impact and acquisition funding certainty.

Evidence & confidence

The filing is a primary-source 8-K disclosing the size and structure of the term loan used to fund transactions and partially fund LaCorium, which can affect leverage and refinancing risk.

Market effects

Sector

Signals continued M&A financing in consumer healthcare; may influence lender appetite/terms for similar issuers.

Regional

Limited; primarily US credit/NYSE-listed issuer impact.

Global

Low; transaction financing is US-centric and deal timing is tied to fiscal 2027.

Counterpoint

What could challenge this read

The facility’s optional second draw and ability to prepay (with defined premium) could reduce downside risk versus a fully committed, inflexible structure.

Key entities

  • company
    Prestige Consumer Healthcare Inc.

    Issuer that entered the term loan facility and guarantees obligations under the credit agreement.

  • acquired_company
    LaCorium Health

    Acquisition referenced as expected to close in Q2 fiscal 2027, partially funded via permitted second-draw term loans.

  • lender_agent
    Citibank, N.A.

    Administrative agent for the term loan credit agreement.

Read at source← All news

Related articles

AUG 13
$PBHMed

Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover?

Prestige Consumer Healthcare (NYSE:PBH) reported Q1 fiscal 2027 sales of $265.7M (+6.5% YoY) and adjusted diluted EPS of $0.98. The company closed Breathe Right (June 12) and LaCorium Health (July 1), adding about $240M annualized revenue and raising FY sales guidance to $1.29B-$1.315B and adjusted EPS to $4.55-$4.65. Clear Eyes faces supply constraints; acquisitions were funded with new debt.

insidermonkey.com6 min
AUG 13
$PBHMed

Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript

Prestige Consumer Healthcare (PBH) reported Q1 fiscal 2027 sales of about $266 million, up 6.5%, with growth led by GI brands such as Dramamine and Fleet and skin care brands including Compound W. Adjusted EPS rose to $0.98 and adjusted free cash flow reached $83.7 million. PBH also completed acquisitions of the Breathe Right portfolio (closed June 12) and LaCorium (July 1).

yahoo.com10 min
AUG 6
$PBHMedAI 8/10

PREMIUM BRANDS HOLDINGS CORPORATION REPORTS RECORD SECOND QUARTER SALES, ADJUSTED EBITDA AND ADJUSTED EARNINGS AND DECLARES THIRD QUARTER DIVIDEND

Premium Brands Holdings (TSX: PBH) reported record Q2 2026 results. Revenue rose to $2.4B, up 26.3% year over year, with 7.5% organic sales growth. Adjusted EBITDA from continuing operations increased to $225.0M and adjusted EPS to $1.53. The company declared a $0.85 dividend for Q3 and revised 2026 guidance due to delayed promotions/new product launches.

leaderpost.com6 min
AUG 6
$PBHHigh

Prestige Consumer Healthcare Inc. (PBH): Results of Operations and Financial Condition

Prestige Consumer Healthcare Inc. (PBH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991fy27-q1earningsr.htm EX-99.1 Document Exhibit 99.1 Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results • Q1 Revenue of $265.7 million up 6.5% versus prior year • Q1 Organic sales growth of 3.2%, exceeding expectations • Q1 Diluted EPS o

SEC EDGAR 8-K6 min
AUG 26
$VCTRHighAI 9/10

Why is Victory Capital stock surging today?

Victory Capital (VCTR) stock rose 3.7% to a 52-week high of $119.61 after announcing a $7.0 billion deal to acquire First Eagle Investments, which manages $222 billion in assets. The combined entity will oversee $571 billion in total assets. The acquisition includes $4.4 billion in cash, $2.0 billion in Victory Capital equity, and assumption of $575 million in debt. The broader market had minimal impact on the move.

investing.com2 min